Private Capital's PFE Position Overview
Private Capital (via Private Capital Management, LLC) currently holds 89,909 shares of Pfizer Inc. (PFE) worth $2.24 M, representing 0.21% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Private Capital has maintained a strategic position in PFE, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 39,500 shares. Largest reduction occurred in Q4 2025, reducing 13,891 shares.
Analysis based on 13F filings available since 2013 Q2
Private Capital's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Private Capital
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -13,891 | Reduce 13.38% | 89,909 | $24.90 |
| Q3 2025 | +17,308 | Add 20.01% | 103,800 | $25.48 |
| Q2 2025 | +10,008 | Add 13.09% | 86,492 | $24.24 |
| Q1 2025 | +308 | Add 0.40% | 76,484 | $25.34 |
| Q4 2024 | +3,208 | Add 4.40% | 76,176 | $26.53 |
| Q3 2024 | +3,611 | Add 5.21% | 72,968 | $28.94 |
| Q2 2024 | +30,006 | Add 76.25% | 69,357 | $27.98 |
| Q1 2024 | +1,208 | Add 3.17% | 39,351 | $27.75 |
| Q4 2023 | -8,000 | Reduce 17.34% | 38,143 | $28.79 |
| Q3 2023 | +39,500 | Add 594.61% | 46,143 | $33.17 |
| Q2 2023 | +6,643 | New Buy | 6,643 | $36.68 |
| Q1 2023 | -8,843 | Sold Out | 0 | $0.00 |
| Q3 2022 | +8,843 | New Buy | 8,843 | $43.76 |
Private Capital's Pfizer Investment FAQs
Private Capital first purchased Pfizer Inc. (PFE) in Q3 2022, acquiring 8,843 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital has held Pfizer Inc. (PFE) for 14 quarters since Q3 2022.
Private Capital's largest addition to Pfizer Inc. (PFE) was in Q3 2023, adding 46,143 shares worth $1.53 M.
According to the latest 13F filing for Q4 2025, Private Capital's firm, Private Capital Management, LLC, owns 89,909 shares of Pfizer Inc. (PFE), valued at approximately $2.24 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.21% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings.
Private Capital's peak holding in Pfizer Inc. (PFE) was 103,800 shares, as reported at the end of Q3 2025.